# China NMPA Drug Inspection - Harbin Pharmaceutical Group General Pharmaceutical Factory - Amoxicillin clavulanate potassium dispersible tablets

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/harbin-pharmaceutical-group-general-pharmaceutical-factory/19ed76cb-22f6-4188-87a4-798957442bbb/
Source feed: China

> China NMPA drug inspection for Harbin Pharmaceutical Group General Pharmaceutical Factory published October 19, 2018. Drug: Amoxicillin clavulanate potassium dispersible tablets. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Jiangxi Province 2018 No. 7 Drug Supervision and Sampling Inspection Information Announcement
- Company Name: Harbin Pharmaceutical Group General Pharmaceutical Factory
- Publication Date: 2018-10-19
- Drug Name: Amoxicillin clavulanate potassium dispersible tablets
- Inspection Finding: Compliant

Company: https://www.globalkeysolutions.net/companies/harbin-pharmaceutical-group-general-pharmaceutical-factory/d6f60073-33ea-44c6-a400-c20fe15b4b0d/